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Background: The metabolic syndrome (MS) is characterized by several cardiovascular risk factors and is associated
with an increased incidence of diabetes, cardiovascular events and mortality. The prevalence of MS is increasing in
epidemic proportions worldwide. The present study aimed to investigate the prevalence of MS and its components
in health professionals in the municipality of Viçosa, Brazil.
Methods: Cross-sectional observational study in the frame of the LATIN America METabolic Syndrome (LATINMETS)
multicenter study. The study sample consisted of 226 healthcare personnel (20–59 years). Weight, height, waist
circumference and hip circumference were determined. The following anthropometric indices were calculated: body
mass index (BMI), waist/hip ratio, waist/height ratio, body adiposity index (BAI) and conicity index. Body composition
was assessed by tetrapolar bioelectrical impedance. The lipid profile, fasting glucose, insulin, uric acid, high-sensitive
C-reactive protein (hs-CRP) and complement C3 were measured in fasting conditions. Insulin resistance was assessed
by the Homeostasis Model Assessment Index of Insulin Resistance (HOMA-IR).
Results: Of the 226 healthcare individuals included in the study, 74.3% were female, 77.0% graduated and 23.0%
students of the last two years of courses in health area, with a median age of 27 years. The overall prevalence of MS
was 4.5%, and increased with age (20 to 29 years: 1.3%; 30 to 39 years: 5.6%; ≥ 40 years: 26.3%) (P < 0.01). The presence
of pre-MS and MS was associated with several measures of adiposity, total cholesterol/HDL-c and LDL-c/HDL-c ratios
and serum complement C3 concentrations.
Conclusions: The LATINMETS Brazil study reported an association between MS prevalence and age, especially in
those over 40 years. The presence of MS is associated with an increased prevalence of several cardiovascular risk
factors.
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Metabolic syndrome (MS) is a set of risk factors for
cardiovascular disease, characterized by the presence of
abdominal obesity, high fasting glucose, atherogenic
dyslipidemia and high blood pressure [1-3]. MS is related
to other comorbidities including, prothrombotic state,
proinflammatory state, non-alcoholic steatohepatitis and
reproductive disorders [4]. MS is also associated with* Correspondence: fcvidigal@gmail.com
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unless otherwise stated.increased risk of type 2 diabetes, cardiovascular disease
and mortality from all causes [5]. Furthermore, there is
evidence that MS is a simple and effective clinical
tool to identify individuals predisposed to high risk of
cardiovascular disease and type 2 diabetes. Similarly,
components of MS are independently associated with
cardiovascular disease and type 2 diabetes, becoming
targets of therapeutic changes in lifestyle, medications
and surgery [6-8].
Accordingly, the prevalence of MS is increasing in
epidemic proportions in both developed countries and
developing countries [4]. The worldwide prevalence of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and 25% [9]. According to data from the National
Health and Nutrition Examination Survey (NHANES)
2009–2010, about one-fifth of the adult population of
the United States had high cardiometabolic risk, with the
prevalence of MS (adjusted for age) being estimated at
22.9% [8]. Vidigal et al. [10], in a recent systematic review,
identified MS prevalence ranging between 4.9% and 65.3%
in the adult Brazilian population, including urban, rural
and indigenous populations. Health professionals are an
important population subgroup, since they are committed
to health promotion and prevention, or treatment of
diseases, which affect not only their own health but also
communities, families and individuals with which they
work [11]. The aim of the present study was to assess
the prevalence of MS and its components in health
professionals in the municipality of Viçosa, Minas




This is a cross-sectional observational study conducted
in Viçosa, Brazil that integrates the multicentric LATIN
America METabolic Syndrome (LATINMETS) study,
coordinated by Universitat Rovira i Virgili in Reus,
Spain, with the same criteria to define the study
population and the diagnosis of MS in five Latin
American countries (Argentina, Brazil, Colombia,
Mexico and Paraguay) [1,11].
The project was approved by the Ethics Committee
on Human Research (Of. Ref No 005/2011) of the
Universidade Federal de Viçosa, in accordance with
the principles of the Declaration of Helsinki. Participants
were informed about the research objectives and the
methodology to be used and signed the Informed
Consent Form.
Target population and the study sample
The population of the Brazil LATINMETS study consisted
of health professionals between 20 and 59 years of age.
We conducted a survey of 976 healthcare professionals in
Viçosa. The calculated sample size was 223 individuals,
considering a confidence level of 95%, sampling error of 5%
and expected MS prevalence of 25%. Health professionals
were invited to participate in the study via phone
calls, disclosure on websites, social networks, local radio
and pamphlets.
As criteria for inclusion we considered health profes-
sional (doctors, nurses, nutritionists, physical trainers,
physiotherapists, dentists, pharmacists, biochemists and
psychologists), who worked in health facilities and or in a
higher education institution, and students in their last two
years of courses in the health area. Women who werepregnant or breastfeeding, individuals using steroids or
antibiotics at the time of inclusion in the study, individuals
who had an illness that required hospitalization at the
time of the study, individuals with cancer or who had
cancer in the past three years, and individuals who
presented difficulties with weighing, measuring, meas-
uring blood pressure or performing blood collection
or presented an inflammatory state were excluded.
Individuals who had serum high-sensitive C-reactive
protein (hs-CRP) above 10 mg/L were also excluded,
for being suggestive of inflammation and/or infection
in activity [12,13].Data collection
Data collection was performed at the Laboratory of
Energy Metabolism and Body Composition (LAMECC)
and in the Clinical Analyzes Laboratory (LAC), Department
of Nutrition and Health at the Universidade Federal de
Viçosa, from January 2012 to July 2013.Sociodemographic assessment and physical activity
Information regarding the clinical history assessing
socioeconomic status, personal or family history of
diseases, smoking and medication use was recorded.
The physical activity was assessed using the long-form
International Physical Activity Questionnaire (IPAQ) [14].Anthropometric evaluation and body composition
Weight and height were measured according to the
techniques recommended by the World Health
Organization [15]. Waist circumference (WC) was mea-
sured with the aid of flexible, inelastic tape measure at the
midpoint between the last rib and the iliac crest [15-18].
Hip circumference (HC) was measured in the area of
highest protuberance in the gluteal region with a flexible,
inelastic tape measure. Based on the anthropometric
measurements, the following anthropometric indices
were calculated: body mass index (BMI) that is
reached by dividing the weight (kg) by the height
(m) squared [15,17]; waist/hip ratio (WHpR) ob-
tained by the ratio between the WC (cm) and the
HC (cm) [15]; waist/height ratio (WHtR) obtained by
the ratio between the WC (cm) and the height (cm)
[19]; conicity index (COI) calculated by the following
equation: WC mð Þ=0:109 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃweight kgð Þ=height mð Þp [20]
and body adiposity index (BAI) calculated by the
equation: HC mð Þ=height mð Þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃheight mð Þp −18 [21].
Body composition was assessed by bioelectrical imped-
ance analysis (BIA), using the Biodynamics Model 310®
apparatus, using standardized conditions of measure-
ment [22].
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Blood pressure was measured using an automatic
sphygmomanometer (Omron HEM-742INT), according
to the protocol recommended by the European Society of
Hypertension and the European Society of Cardiology [23].
Biochemical determinations
Blood samples were extracted after 12 hours of fast,
through intravenous puncture in the median antecubital
vein using a vacuum system, with subsequent centrifuga-
tion (2,500 rpm, 4°C, 10 min). The samples properly
separated and identified were stored at −80°C. Fasting
plasma glucose was determined by the glucose oxidase
method; uric acid, total cholesterol, HDL-cholesterol
(HDL-c) and triglycerides by the enzymatic colorimetric
method. LDL-cholesterol (LDL-c) was calculated using
the Friedewald formula [24]. Insulin was measured by
the electrochemiluminescence method. Plasma hs-CRP
and the complement C3 concentrations were measured by
nephelometry.
The insulin resistance was assessed by HOMA-IR
(Homeostasis Model Assessment - Insulin Resistance)
index, calculated by the following equation: [insulin(µU/
mL) × fasting plasma glucose(mmol/L)]/22, 5 [25].
Definition of metabolic syndrome
MS has been defined as the presence of three or more of
the five risk factors established by the International
Diabetes Federation (IDF) and the American Heart
Association/National Heart, Lung, and Blood Institute
(AHA/NHLBI) [1]: 1) abdominal obesity (WC ≥ 90 cm in
men and ≥ 80 cm in women); 2) hypertriglyceridemia
(triglycerides ≥ 150 mg/dL or use of medications to
lower triglycerides); 3) low HDL-c (<40 mg/dL in
men and <50 mg/dL in women or use of medication
to increase HDL-c); 4) high blood pressure (systolic
blood pressure ≥130 mmHg and or diastolic blood
pressure ≥85 mmHg or use of antihypertensive medication);
5) high fasting plasma glucose ≥100 mg/dL or use of
hypoglycemic medication).
Definition of pre-metabolic syndrome (pre-MS)
Pre-metabolic syndrome (pre-MS) was defined as having
no less than two components of MS but did not meet
the criteria for the diagnosis of MS [26].
Statistical analyzes
MS was coded as a dichotomous variable (presence or
absence) as well as the number of MS components
(discrete continuous variable). In the descriptive statistics
the quantitative variables with normal distribution were
expressed as mean and standard deviation, and the
nonparametric variables as median and interquartile range,
according to the Kolmogorov-Smirnov test. Qualitativevariables were presented as frequency distribution. We
used the chi-square (χ2) of Pearson tests to compare
proportions. For comparison of means the Student t-test
and analysis of variance (ANOVA) with post hoc Tukey
test for normally distributed variables were used.
Nonparametric variables were analyzed using the
Mann–Whitney and Kruskal-Wallis with post hoc
Dunn's test. Odds ratios (ORs) were estimated to assess
the association between the variables studied and the MS
and their confidence intervals (CI) of 95% using simple
logistic regression analysis. The significance level (α)
adopted for all hypothesis tests was 5%. Statistical analysis
was performed with SPSS for Windows (version 17.0,
SPSS Inc, Chicago, IL).
Results
238 health professionals aged 20 to 59 years were evaluated,
of which 226 concluded the study, constituting the final
sample. Of the 226 health professionals included in the
study, 74.3% were female, 77.0% graduated and 23.0%
students in the last two years of health courses, with
an average age of 27 years. According to their areas
of expertise, 51.8% were in the nutrition area (64.3%
female) and 25.7% in physical education (58.6% men).
Regarding socioeconomic status, 56.1% were classified
as class B, according to the criteria of the Brazilian
Association of Research Companies (ABEP) [27]. The
majority (86.1%) had active standard of physical activity
and were non-smokers (95.2%). As to medications, 3.1%
used antihypertensives; 1.3% hypolipidemics; 0.4% oral
hypoglycaemics and/or insulin, with no differences
between the sexes, and 39.3% of the women were using
contraceptives. Systolic blood pressure, diastolic blood
pressure, BMI, WC, HC, WHpR, WHtR, lean mass,
fasting glucose and uric acid were higher in men than in
women, while BAI, body fat percentage, fat mass, HDL-c,
hs-CRP and complement C3 were higher in women
(P <0.05) (data not shown).
According to nutritional status, 4.9% (n = 11) of partici-
pants were classified as underweight, 73.9% (n = 167)
normal weight, 17.7% (n = 40) were overweight and
3.5% (n = 8) obese, according to the World Health
Organization classification [28].
Table 1 presents the prevalence of MS and its compo-
nents. The prevalence of MS was 4.5% (95% CI: 1.7 to
7.2) among health professionals, with no significant
difference between sexes. High blood pressure (24.1%),
abdominal obesity (20.7%) and low HDL-c (19.0%) were
the most prevalent components of MS among men,
while abdominal obesity (26.2%), low HDL-c (19.3%) and
hypertriglyceridemia (12.0%) were more prevalent in
women. The presence of high blood pressure and high
fasting plasma glucose MS components was higher
among men (P <0.01).
Table 1 Metabolic syndrome and its components in health professionals
Total (n = 226) Men (n = 58) Women (n = 168) P
Metabolic syndrome, % (CI 95%) 4.5 (1.7-7.2) 8.6 (1.2-16.1) 3.0 (0.4-5.6) 0.075
Metabolic syndrome components, % (CI 95%)
Abdominal obesity 24.8 (2.9-19.1) 20.7 (9.9-31.4) 26.2 (19.5-32.9) 0.403
Hypertriglyceridemia 11.6 (7.4-15.8) 10.3 (2.3-18.4) 12.0 (7.0-17.1) 0.727
Low HDL-c 19.2 (14.0-24.4) 19.0 (8.6-29.4) 19.3 (13.2-25.3) 0.959
High blood pressure 9.3 (5.5-13.2) 24.1 (12.8-35.5) 4.2 (1.1-7.3) <0.01
High fasting plasma glucose 7.1 (3.7-10.5) 15.5 (5.9-25.1) 4.2 (1.1-7.3) < 0.01
Abbreviations: CI confidence interval, HDL-c HDL-cholesterol.
Chi-squared Test (χ2).
Overall prevalence, stratified by sex. Viçosa, Minas Gerais, 2014.
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oldest categories, as well as the prevalence of abdominal
obesity and high fasting plasma glucose components
(Table 2).
Table 3 describes the characteristics of health profes-
sionals according to the number of MS components as a
function of the variables studied. According to gender,
20.7% of men and 11.4% of the women presented two or
more components. The presence of three or more
components of metabolic syndrome was more common
in subjects over 40 years of age (26.3%). Analyzing the
education level, 15.7% of graduates and 7.6% of students
presented two or more components. According to the
area of expertise, graduates, and or nutrition (13.0%)
and physical education students (10.3%) had two or
more components. Considering the socioeconomic
level, the frequency of three or more components was
similar between the highest (13.3%) and the lowest
class (11.1%). The presence of three or more compo-
nents was higher among the non-active (12.9%) compared
to active individuals (3.1%). Analyzing the nutritional
status, 20.8% of overweight individuals had three or
more MS components, while no eutrophic subjects
exhibited more than two components. It is note-
worthy that no health professional presented all five
MS components.Table 2 Prevalence of metabolic syndrome and its componen
20 to 29 years (n = 151)
Metabolic syndrome, % (CI 95%) 1.3 (−0.5-3.2)
Metabolic syndrome components, % (CI 95%)
Abdominal obesity 15.2 (9.4-21.0)
Hypertriglyceridemia 9.9 (5.1-14.8)
Low HDL-c 15.9 (10.0-21.8)
High blood pressure 7.3 (3.1-11.5)
High fasting plasma glucose 5.3 (1.7-8.9)
Abbreviations: HDL-c HDL-cholesterol.
Chi-squared Test (χ2).
Viçosa, Minas Gerais, 2014.Diastolic blood pressure, BMI and HC increased with
the number of MS components. Health professionals
with two or more components showed higher values of
age, weight, WC, WHpR, COI, WHtR, body fat percentage,
fat mass, triglycerides, and HOMA-IR and lower HDL-c
compared with those who had one or no component.
Health professionals with MS had higher levels of systolic
blood pressure, insulin and complement C3 compared with
subjects with one or no component. Those with MS had
higher BAI values and higher uric acid concentrations com-
pared to individuals without MS. Height, total cholesterol,
fasting glucose and hs-CRP did not differ between groups
(Tables 4 and 5).
The pre-MS, i.e., the presence of two MS components,
was associated with BMI, body fat percent, total choles-
terol/HDL-c and LDL-c/HDL-c ratios and complement
C3. For each increase of 1 kg/m2 in BMI and 1% in body
fat there was an increase of 36% and 12% in the risk of
pre-MS. Regarding biochemical indices evaluated, for
each increase of 1 unit in total cholesterol/HDL-c and
LDL-c/HDL-c ratios, the risk for pre-MS was 2.53 fold.
For each increase of 1 mg/dL of complement C3
concentrations, the risk of MS was 1.03 fold higher. MS
was positively associated with age, physical inactivity,
BMI, BAI, body fat percentage, total cholesterol/HDL-c
and LDL-c/HDL-c ratios, uric acid, and complement C3.ts in health professionals, according to age group
30 to 39 years (n = 55) ≥40 years (n = 20) P
5.6 (−0.8-11.9) 26.3 (4.5-48.1) <0.01
34.5 (21.6-47.5) 70.0 (48.0-92.0) <0.01
13.0 (3.7-22.2) 21.1 (0.9-41.2) 0.339
22.2 (10.8-33.7) 36.8 (13.0-60.7) 0.074
11.1 (2.5-19.8) 20.0 (0.8-39.2) 0.162
9.3 (1.3-17.2) 15.8 (−2.3-33.9) <0.01
Table 3 Number of metabolic syndrome components
according to the health professional characteristics
Variables n Number of components (%)
0-1 2 ≥3
Gender
Men 58 79.3 12.1 8.6
Women 166 88.6 8.4 3.0
Age (years)
20 to 29 151 92.7 6.0 1.3
30 to 39 54 77.8 16.7 5.5
≥40 19 57.9 15.8 26.3
Educational Level
Graduates 172 84.3 11.0 4.7
Students 52 92.4 3.8 3.8
Area
Nutrition 115 87.0 10.4 2.6
Physical Education 58 89.7 8.6 1.7
Others 51 80.4 7.8 11.8
Socioeconomic level
Class A 30 83.4 3.3 13.3
Class B 119 84.9 11.8 3.3
Class C 53 86.8 11.3 1.9
Class D 9 88.9 0.0 11.1
Life Style
Non-active 31 74.2 12.9 12.9
Active 191 88.0 8.9 3.1
Smoking
Non-smoker 198 85.9 10.1 4.0
Smoker 7 85.7 0.0 14.3
Ex-smoker 2 100.0 0.0 0.0
BMI (kg/m2)
<25 176 94.3 5.7 0.0
≥25 48 56.3 22.9 20.8
Abbreviations: BMI body mass index.
Viçosa, Minas Gerais, 2014.
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to have MS compared to those less than 40 years.
Non-active health professionals had 4.6 times more
risk to have MS than the active professionals. For
each 1 kg/m2 increase in BMI, 1 unit of BAI and 1%
body fat, there was a 75%, 32% and 18% increased
risk of MS, respectively. Regarding biochemical indices
evaluated, for each increase of 1 unit in total cholesterol/
HDL-c and LDL-c/HDL-c ratios, the risk for having MS
was 3.38 and 2.49 fold higher, respectively. For each
increase of 1 mg/dL in the concentrations of uric acid and
complement C3, the risk of having MS was 2.06 and 1.06
times higher, respectively (Table 6).Discussion
The LATINMETS Brazil study reported an overall MS
prevalence of 4.5% (95% CI: 1.7 to 7.2) in health care
workers, with no significant difference between the sexes,
according to the criteria established by the IDF and the
AHA/NHLBI. The prevalence of MS reported in this
study was lower than previously published, according to
different criteria for defining the MS [7,8,10,11,29-31].
The LATINMETS Columbia study identified an MS
prevalence of 17.5% among the health professionals
evaluated (n = 285), using the same criteria of the present
study [11]. NHANES data show a reduction in the
prevalence of MS in the United States from 25.5% in
1999–2000 to 22.9% in 2009–2010, according to the
criteria established by the IDF and the AHA/NHLBI [8].
In Mexico, the prevalence of MS ranged between 13.6%
and 26.6% depending on the diagnostic criteria used [29].
The overall prevalence estimated by the CARMELA study
that evaluated MS in seven Latin American countries
(Argentina, Chile, Colombia, Ecuador, Mexico, Peru and
Venezuela) was 21.0%, according to the criteria of the
National Cholesterol Education Program Adult Treatment
Panel III (NCEP-ATP III) [7]. Bustos et al. identified MS
prevalence of 7.6% in an urban population in Brazil and
10.1% in a semi-rural population of Chile [30], while
Silva et al. [31] reported MS prevalence of 15.4% in a
rural population in Brazil, according to the criteria of
NCEP-ATP III. A recent systematic review estimated
the prevalence of MS at 29.6% of the adult Brazilian
population, using different criteria for the definition
of MS [10].
Although the overall prevalence of MS was low, it was
found that it increased with age, presenting as elevated
in individuals over 40 years of age (26.3%). This finding
was also reported by the LATINMETS Colombia study
[11]. Corroborating these findings, all Latin American
countries evaluated by the CARMELA study showed an
increased prevalence of MS with age [7], as in the studies
of the Brazilian population [32,33].
According to socioeconomic status, the prevalence of
MS was similar between the highest level (Class A) and
the lowest (Class D) of the sample. It is noteworthy that the
majority (70.7%) belonged to the highest socioeconomic
levels (Classes A and B) and only 4.2% were Class D, with
no participant framed in Class E. Buckland et al. [2] found
that MS remained associated with low socioeconomic
status, after adjustment for confounders. Accordingly,
Bustos et al. [30] assessed the prevalence of MS in two
countries with different socioeconomic levels, and their
results suggest the existence of a cultural, educational and
socioeconomic phenomenon that possibly influences the
prevalence of diagnosis of MS components based on
differences in lifestyle, rather than belonging to a par-
ticular place. It is noteworthy that the sample was
Table 4 Number of metabolic syndrome components according to age, blood pressure and adiposity indicators
Number of components P
0-1 2 ≥3
(n = 193) (n = 21) (n = 10)
Age (years)* 26 (24–30)a 30 (26.0-35.5)b 37.5 (28.3-46.0)b <0.01
Blood pressure
Systolic (mmHg) * 105.3 (100.1-114.4)a 116 (102.5-125.0)ab 125.5 (119.7-132.6)b <0.01
Diastolic (mmHg)† 66.1 ± 6.8a 71.7 ± 9.0b 79.3 ± 8.4c <0.01
Anthropometric indicators
Weight (kg)* 59.3 (53.9-68.1)a 68.9 (60.8-82.3)b 84.7 (73.3-90.2)b <0.01
Height (cm)† 1.67 ± 0.08a 1.69 ± 0.08a 1.67 ± 0.09a 0.669
BMI (kg/m2)† 22.0 ± 2.7a 25.0 ± 3.6b 30.6 ± 4.9c <0.01
WC (cm)* 76 (71–82)a 85 (80.0-92.7)b 103.8 (89.3-107.4)b <0.01
HC (cm)† 97.9 ± 5.7a 101.7 ± 6.8b 108.2 ± 11.4c <0.01
WHpR* 0.78 (0.74-0.83)a 0.83 (0.79-0.90)b 0.94 (0.90-1.01)b <0.01
BAI† 27.4 ± 3.5a 28.5 ± 4.3a 32.2 ± 4.8b <0.01
COI* 1.16 (1.12-1.20)a 1.21 (1.17-1.28)b 1.33 (1.26-1.37)b <0.01
WHtR* 0.45 (0.43-0.49)a 0.51 (0.47-0.54)b 0.62 (0.55-0.68)b <0.01
Body composition
Body fat (%)† 21.9 ± 6.1a 26.1 ± 6.6b 28.8 ± 8.5b <0.01
Fat mass (kg)* 12.9 (10.4-15.8)a 17 (15.3-20.3)b 24 (16.7-29.9)b <0.01
Lean mass (kg)* 45.2 (41.6-52.7)a 50.2 (44.9-64.0)ab 58.7 (49.0-68.8)b <0.01




ANOVA with post hoc Tukey test for parametric variables. Kruskal-Wallis test with post hoc Dunn’s test for nonparametric variables. Comparison between columns.
Different letters indicate statistical difference between the values presented.
Viçosa, Minas Gerais, 2014.
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students, thus homogeneous as to the degree of edu-
cation. Therefore, our results are not comparable when
considering the general population.
MS was more frequent among non-active health pro-
fessionals and was present only in individuals who are
overweight. The combination of physical inactivity and
obesity are associated with insulin resistance, which may
explain the increased prevalence of MS in these individ-
uals [4,34,35]. The LATINMETS Colombia study found
that the prevalence of MS in individuals with excess
weight was ten times higher compared to those with a
normal BMI [11].
HC and BMI increased with the number of MS
components. Health professionals with two or more
components presented higher values of age, weight,
WHpR, COI, WHtR, body fat percentage, fat mass,
triglycerides, and HOMA-IR and lower HDL-c compared
with those who had one or no component. It appears that
the presence of two MS components is capable of identify-
ing higher values of anthropometric indicators of obesity,
atherogenic dyslipidemia, and insulin resistance index. Itcan be speculated pre-MS [26,36,37] is able to identify
anthropometric indicators and metabolic changes, show-
ing that this early stage preceding the MS is also character-
ized by an increased risk of atherosclerotic complications
and insulin resistance.
In the present study, the prevalence of pre-MS was
12.1% and 8.4% in men and women respectively. It is
noteworthy that when comparing individuals with pre-MS
with those with MS, few parameters were statistically
different, a fact that reveals a rather unsatisfactory health
profile, in those even without installed MS.
Health professionals with MS had higher insulin, and
complement C3 concentrations compared with subjects
with one or no component. Subjects with MS showed
higher BAI and higher uric acid concentrations compared
with those without MS. The BAI, based on measurements
of HC and height, has been suggested as an adiposity
index better correlated with the body fat percentage
than the BMI [21,38]. Data from the study Triglyceride and
Cardiovascular Risk in African-Americans (TARA), identi-
fied a correlation between the body fat percentage, assessed
by Dual Emission X-ray absorptiometry (DXA), and a BAI
Table 5 Number of metabolic syndrome components according to biochemical parameters
Number of components P
0-1 2 ≥3
(n = 193) (n = 21) (n = 10)
Biochemical parameters
Total cholesterol (mg/dL)† 183.5 ± 35.9a 190.1 ± 40.1a 183.9 ± 39.9a 0.735
HDL-c (mg/dL)† 61.3 ± 14.6a 51.2 ± 14.3b 39.7 ± 6.9b <0.01
Triglycerides (mg/dL)* 82 (58–105)a 115 (79–150)b 206.5 (101.5-251.5)b <0.01
Fasting glucose (mg/dL)* 85.5 (80–92)a 90 (80.5-101.0)a 93.5 (86–102)a 0.052
Insuline (μUI/mL)* 6.2 (4.4-8.6)a 7.8 (5.8-9.6)ab 13.9 (7.6-17.5)b <0.01
HOMA-IR* 1.29 (0.90-1.84)a 1.75 (1.20-2.02)b 2.85 (1.79-3.98)b <0.01
Uric acid (mg/dL)† 3.99 ± 1.14a 4.2 ± 0.91a 5.4 ± 1.53b <0.01
hs-CRP (mg/L)* 1.00 (0.65-2.00)a 1.50 (0.64-6.25)a 3.00 (0.72-5.50)a 0.231
Complement C3 (mg/dL)† 103.7 ± 17.7a 113.4 ± 14.6ab 127.7 ± 22.7b <0.01
Abbreviations: HDL-c HDL-cholesterol, HOMA-IR Homeostasis Model Assessment - Insulin Resistance, hs-CRP high-sensitive C-reactive protein.
*Nonparametric variables.
†parametric variables.
ANOVA with post hoc Tukey test for parametric variables. Kruskal-Wallis test with post hoc Dunn’s test for nonparametric variables. Comparison between columns.
Different letters indicate statistical difference between the values presented.
Viçosa, Minas Gerais, 2014.
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found that the BAI was not better than WC and BMI
in predicting body fat percentage, metabolic abnormalities
and subclinical atherosclerosis in Chinese populations.
Hyperuricemia, even in asymptomatic clinical manifesta-
tions, is a cardiometabolic risk factor in adults [37]. In
agreement with the present study, Desai et al. [39] demon-
strated that concentrations of uric acid increased linearly
with the increasing number of MS components in
Brazilian men (46 ± 7 years old). In addition, uric acid has
been found to be a reliable indicator of pre-MS in obeseTable 6 Odds ratio for the association between age,
physical activity patterns, adiposity indicators and
biochemical parameters, and pre-metabolic syndrome
and metabolic syndrome, in health professionals
Variables Pre-MS MS
OR (CI 95%) OR (CI 95%)
Age (≥40 years) 2.76 (0.70-10.80) 14.29 (3.69-55.26)
Physical activity patterns
(non-active)
1.72 (0.53-5.55) 4.57 (1.21-17.24)
BMI (kg/m2) 1.36 (1.17-1.58) 1.75 (1.35-2.27)
BAI 1.08 (0.96-1.22) 1.32 (1.13-1.56)
Body fat (%) 1.12 (1.04-1.21) 1.18 (1.06-1.32)
Total cholesterol /HDL-c 2.53 (1.54-4.15) 3.38 (1.89-6.05)
LDL-c/HDL-c 2.53 (1.44-4.46) 2.49 (1.28-4.86)
Uric acid (mg/dL) 1.18 (0.79-1.75) 2.06 (1.32-3.22)
Complement C3 (mg/dL) 1.03 (1.00-1.06) 1.06 (1.02-1.09)
Abbreviations: Pre-MS pre-metabolic syndrome, MS metabolic syndrome,
OR odds ratio, CI confidence interval, BMI body mass index, BAI body adiposity
index, HDL-c HDL-cholesterol, LDL-c LDL-cholesterol.
Viçosa, Minas Gerais, 2014.adolescents (10 to 15.9 years old) [37]. Corroborating
these data, studies in Asian populations (China, South
Korea, Thailand and Japan) also found an association
between metabolic syndrome and uric acid concentrations
[40-43]. Phillips et al. [44] reported a three-fold higher risk
of having MS and its phenotypes, including abdominal
obesity, insulin resistance and low concentrations of
HDL-c in subjects with higher concentrations of comple-
ment C3 (> median), an acute phase protein with an
important function in the innate immune system.
Onat et al. [45] demonstrated that the complement C3
were positively associated with WC, triglycerides and
hs-CRP concentrations, and inversely with smoking
status. Moreover, the concentrations of complement
C3 were able to predict the presence of MS.
In the present study, the pre-MS and the MS were asso-
ciated with BMI, percent total body fat, total cholesterol/
HDL-c and LDL-c/HDL-c ratios and complement C3 con-
centrations. In addition to these variables, the MS was posi-
tively associated with age, physical inactivity, BAI and uric
acid. Buckland et al. found that, after adjustment for
confounders, the MS was positively associated with
the male gender, age, BMI, physical inactivity and low
socioeconomic status, whereas smoking and marital
status were not associated with MS [2]. Participants
of the Coronary Artery Risk Development in Young
Adults (CARDIA) study with higher initial BMI who did
not drink alcohol (compared with one to three drinks per
day), with higher carbohydrate intake and lower fiber
intake had higher MS risk (relative risk: 1.3 to 1.9), while
the physical activity had a protective association (relative
risk: 0.84, 95% CI: 0.76 to 0.92) [46].
Vidigal et al. Diabetology & Metabolic Syndrome  (2015) 7:6 Page 8 of 9The main limitations of the present study are the
characteristics inherent in a cross-sectional study, i.e.,
the associations between MS and variables cannot be
interpreted as causal associations. Furthermore, one
should be cautious when interpreting the differences
between the sexes due to the small sample of men in
our study. Another limitation presented refers to the
questionnaire used to assess physical activity. The IPAQ,
despite being an internationally validated instrument, is
not the best method to estimate physical activity, because
it tends to overestimate the number of active individ-
uals [47]. The ideal would be to use pedometers or accel-
erometers. However, among the available instruments in
this study, the IPAQ was the most appropriate.
Conclusions
The LATINMETS Brazil study reported low overall
prevalence of MS among health professionals compared
with data from the scientific literature. We observed an
increase in the prevalence of MS with age, verifying high
prevalence in individuals over 40. MS was associated
with changes in several anthropometric and metabolic
indicators, and was present only in individuals who are
overweight. Pre-MS and MS were associated with
measures of adiposity, total cholesterol/HDL-c and
LDL-c/HDL-c ratios and complement C3, revealing a
rather unsatisfactory health profile even in individuals
without MS installed. It is up to government agencies
and health professionals to discuss the issue and the
implementation of public health policies with the aim of
contributing to excess weight reduction and the incentive
to practice healthy lifestyle habits, and consequent preven-
tion of this problem in the population.
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